Forbes Under 30 alumnus Chase Feiger has raised over $11 million to build a new business, this time aimed at providing a direct-to-consumer platform for pharmaceutical companies.
With RxDefine, This Under 30 Cofounder Is Moving From Manufacturing To Healthcare
